News & Updates
Filter by Specialty:

Early initiation of a soluble guanylate cyclase stimulator in an elderly patient with refractory HFrEF
The patient was an 80-year-old male with multiple comorbidities, including diabetes mellitus controlled with a sodium-glucose cotransporter-2 inhibitor (SGLT2i), hypertension and coronary artery disease, for which he underwent stenting in October 2023. He also had a pacemaker implanted for heart block. His left ventricular ejection fraction (LVEF) ranged between 40–50 percent. For several years, he had been managed as an outpatient for mild heart failure (HF) symptoms and maintained independence in activities of daily living (ADL).
Early initiation of a soluble guanylate cyclase stimulator in an elderly patient with refractory HFrEF
23 Apr 2025
Is catheter ablation safe for treatment of ventricular arrhythmias in early phase after ACS?
Catheter ablation appears to be an effective procedure for patients with ventricular arrhythmias in the early phase following acute coronary syndrome (ACS), as shown by a study presented at EHRA 2025.
Is catheter ablation safe for treatment of ventricular arrhythmias in early phase after ACS?
20 Apr 2025
Etripamil nasal spray safe, effective against PSVT
Treatment with self-administered etripamil results in the termination of paroxysmal supraventricular tachycardia (PSVT) episodes among Chinese patients in an at-home setting, according to a study presented at EHRA 2025.
Etripamil nasal spray safe, effective against PSVT
19 Apr 2025
LBB performs better than standard BiV pacing for CRT in chronic heart failure
For chronic heart failure patients requiring cardiac resynchronization therapy (CRT), the use of left bundle branch (LBB) pacing yields superior clinical outcomes compared with the traditional biventricular (BiV) pacing, as shown in the results of the HeartSync-LBBP trial.